Pharmaceuticals · Key players

Top Hemophilia Treatment companies

The 6 key players our Hemophilia Treatment report profiles, and other companies free public records show in this market.

Key players in Hemophilia Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Hemophilia Treatment market
#CompanyWebsiteOur reports
1 Roche roche.com (opens in a new tab) 1,485 reports
2 Novo Nordisk A/S novo.com (opens in a new tab) 495 reports
3 Takeda Pharmaceutical Company Ltd takeda.com (opens in a new tab) 660 reports
4 Sanofi sanofi.com (opens in a new tab) 1,386 reports
5 CSL Behring — 231 reports
6 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports

Also active in Hemophilia Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Hemophilia Treatment, from free public records
CompanyWhere public records show them
Gland
Ubi
Caplin
Bayer AG
Heritage Pharma
Sagent Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc
Suzhou Alphamab Co., Ltd.
Avet Lifesciences
Swedish Orphan Biovitrum
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
J Molner

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Hemophilia Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Pfizer Inc. 9 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Sanofi 7 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Roche 7 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Bayer AG 6 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Novo Nordisk A/S 6 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Suzhou Alphamab Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  7. CSL Behring 4 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Swedish Orphan Biovitrum 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Hemophilia Treatment reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Hemophilia Treatment, with active trials

Get the full Hemophilia Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.